Ayako Moritomo

523 total citations
26 papers, 394 citations indexed

About

Ayako Moritomo is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ayako Moritomo has authored 26 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Ayako Moritomo's work include Cytokine Signaling Pathways and Interactions (9 papers), Microbial metabolism and enzyme function (5 papers) and Pharmacological Effects of Natural Compounds (5 papers). Ayako Moritomo is often cited by papers focused on Cytokine Signaling Pathways and Interactions (9 papers), Microbial metabolism and enzyme function (5 papers) and Pharmacological Effects of Natural Compounds (5 papers). Ayako Moritomo collaborates with scholars based in Japan and Denmark. Ayako Moritomo's co-authors include Takayuki Inoue, Hisao Hamaguchi, Shohei Shirakami, Yutaka Nakajima, Akira Nagashima, Yasuyuki Higashi, Masataka Morita, Takashi Tojo, Kazuo Nakai and Masaya Orita and has published in prestigious journals such as Drug Discovery Today, Bioorganic & Medicinal Chemistry and Journal of Chemical Information and Modeling.

In The Last Decade

Ayako Moritomo

26 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayako Moritomo Japan 13 161 140 82 55 55 26 394
Stephanos Ioannidis United States 13 181 1.1× 125 0.9× 123 1.5× 82 1.5× 35 0.6× 20 370
Masaki Gouda Japan 9 235 1.5× 49 0.3× 85 1.0× 32 0.6× 34 0.6× 11 385
Jacqueline E. Day United States 9 164 1.0× 77 0.6× 146 1.8× 53 1.0× 58 1.1× 12 382
Shin‐ichi Yaguchi Japan 10 371 2.3× 122 0.9× 124 1.5× 67 1.2× 14 0.3× 14 517
Agustin Casimiro‐Garcia United States 12 158 1.0× 156 1.1× 45 0.5× 22 0.4× 48 0.9× 22 368
Dana Davis United States 12 238 1.5× 161 1.1× 46 0.6× 18 0.3× 13 0.2× 16 571
Timothy P. Burkholder United States 13 301 1.9× 161 1.1× 80 1.0× 33 0.6× 15 0.3× 23 506
Jeffrey Tredup United States 10 191 1.2× 109 0.8× 71 0.9× 23 0.4× 26 0.5× 17 360
Bryan D. Marks United States 13 244 1.5× 48 0.3× 83 1.0× 27 0.5× 60 1.1× 17 442
Hisao Hamaguchi Japan 16 111 0.7× 484 3.5× 124 1.5× 32 0.6× 16 0.3× 19 757

Countries citing papers authored by Ayako Moritomo

Since Specialization
Citations

This map shows the geographic impact of Ayako Moritomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Moritomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Moritomo more than expected).

Fields of papers citing papers by Ayako Moritomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayako Moritomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Moritomo. The network helps show where Ayako Moritomo may publish in the future.

Co-authorship network of co-authors of Ayako Moritomo

This figure shows the co-authorship network connecting the top 25 collaborators of Ayako Moritomo. A scholar is included among the top collaborators of Ayako Moritomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayako Moritomo. Ayako Moritomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamasuna, Ryoichi, Hiroyuki Hanzawa, Ayako Moritomo, et al.. (2021). Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains. Journal of Infection and Chemotherapy. 28(3). 377–383. 14 indexed citations
2.
3.
Kato, Koji, et al.. (2019). Optimization of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines to generate a highly selective PI3Kδ inhibitor. Bioorganic & Medicinal Chemistry. 27(6). 1056–1064. 2 indexed citations
4.
Hamaguchi, Hisao, Y. Amano, Ayako Moritomo, et al.. (2018). Discovery and structural characterization of peficitinib (ASP015K) as a novel and potent JAK inhibitor. Bioorganic & Medicinal Chemistry. 26(18). 4971–4983. 66 indexed citations
5.
Kato, Koji, et al.. (2018). Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry. 26(9). 2410–2419. 15 indexed citations
6.
Kato, Koji, et al.. (2018). Optimization and in vivo evaluation of pyrazolopyridines as a potent and selective PI3Kδ inhibitor. Bioorganic & Medicinal Chemistry. 26(14). 3917–3924. 6 indexed citations
7.
Yamagishi, Hiroaki, Takayuki Inoue, Yutaka Nakajima, et al.. (2017). Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitors. Bioorganic & Medicinal Chemistry. 25(20). 5311–5326. 6 indexed citations
8.
Nagashima, Akira, et al.. (2017). Synthesis and pharmacological evaluation of glycine amide derivatives as novel vascular adhesion protein-1 inhibitors without CYP3A4 and CYP2C19 inhibition. Bioorganic & Medicinal Chemistry. 25(15). 4110–4122. 7 indexed citations
9.
Suzuki, Daisuke, et al.. (2016). Synthesis and structure activity relationships of glycine amide derivatives as novel Vascular Adhesion Protein-1 inhibitors. Bioorganic & Medicinal Chemistry. 25(1). 187–201. 11 indexed citations
10.
Nakajima, Yutaka, Naohiro Aoyama, Hiroshi Sasaki, et al.. (2016). Design, synthesis, and evaluation of 4,6-diaminonicotinamide derivatives as novel and potent immunomodulators targeting JAK3. Bioorganic & Medicinal Chemistry. 24(19). 4711–4722. 7 indexed citations
11.
Nakajima, Yutaka, Takayuki Inoue, Kazuo Nakai, et al.. (2015). Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3. Bioorganic & Medicinal Chemistry. 23(15). 4871–4883. 20 indexed citations
12.
Yamagishi, Hiroaki, Shohei Shirakami, Yutaka Nakajima, et al.. (2015). Discovery of 3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2(1H)-one derivatives as novel JAK inhibitors. Bioorganic & Medicinal Chemistry. 23(15). 4846–4859. 17 indexed citations
13.
Moritomo, Ayako, et al.. (2014). Synthesis and pharmacological evaluation of optically pure, novel carbonyl guanidine derivatives as dual 5-HT2B and 5-HT7 receptor antagonists. Bioorganic & Medicinal Chemistry. 22(21). 6026–6038. 4 indexed citations
14.
Nagashima, S., Yuji Matsushima, Hisao Hamaguchi, et al.. (2014). Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry. 22(13). 3478–3487. 11 indexed citations
15.
Moritomo, Ayako, et al.. (2014). Synthesis and structure–activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists. Part 2. Bioorganic & Medicinal Chemistry. 22(15). 4323–4337. 12 indexed citations
16.
Inoue, Takayuki, Masataka Morita, Takashi Tojo, et al.. (2013). Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: Part 2. Bioorganic & Medicinal Chemistry. 21(9). 2478–2494. 14 indexed citations
17.
Moritomo, Ayako, Hiroyoshi Yamada, Toshihiro Watanabe, et al.. (2013). Synthesis and structure–activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists. Bioorganic & Medicinal Chemistry. 21(24). 7841–7852. 12 indexed citations
18.
Inoue, Takayuki, Masataka Morita, Takashi Tojo, et al.. (2013). Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment. Bioorganic & Medicinal Chemistry. 21(13). 3873–3881. 29 indexed citations
19.
Inoue, Takayuki, Masataka Morita, Takashi Tojo, et al.. (2012). Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. Bioorganic & Medicinal Chemistry. 21(5). 1219–1233. 19 indexed citations
20.
Orita, Masaya, Ayako Moritomo, Tatsuya Niimi, & Kazuki Ohno. (2010). Use of Benford's law in drug discovery data. Drug Discovery Today. 15(9-10). 328–331. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanos Ioannidis Breakdown of academic impact, for papers by Masaki Gouda Breakdown of academic impact, for papers by Jacqueline E. Day Breakdown of academic impact, for papers by Shin‐ichi Yaguchi Breakdown of academic impact, for papers by Agustin Casimiro‐Garcia Breakdown of academic impact, for papers by Dana Davis Breakdown of academic impact, for papers by Timothy P. Burkholder Breakdown of academic impact, for papers by Jeffrey Tredup Breakdown of academic impact, for papers by Bryan D. Marks Breakdown of academic impact, for papers by Hisao Hamaguchi
Rankless by CCL
2026